Home pagePRGO • NYSE
add
Perrigo Company PLC
15,09Â $
After Hours:(0,00%)0,00
15,09Â $
Data e ora chiusura: 20 gen, 16:02:14 GMT-5 · USD · NYSE · Disclaimer
Chiusura precedente
15,03Â $
Intervallo giornaliero
14,66Â $ - 15,38Â $
Intervallo annuale
12,17Â $ - 30,93Â $
Cap di mercato
2,08Â Mld USD
Volume medio
3,70Â Mln
Rapporto P/E
-
Dividendo/Prezzo
7,69%
Borsa valori principale
NYSE
Notizie
Dati finanziari
Conto economico
Entrate
Utile netto
| (USD) | set 2025info | Variazione Y/Y |
|---|---|---|
Entrate | 1,04Â Mld | -4,06% |
Spese di gestione | 283,50Â Mln | -2,54% |
Utile netto | 7,50Â Mln | 135,71% |
Margine di profitto netto | 0,72 | 137,31% |
Utili per azione | 0,80 | -1,23% |
EBITDA | 179,00Â Mln | -8,58% |
Aliquota fiscale effettiva | 43,30% | — |
Stato patrimoniale
Totale attivo
Totale passivo
| (USD) | set 2025info | Variazione Y/Y |
|---|---|---|
Investimenti cash/breve termine | 432,10Â Mln | -70,45% |
Totale attivo | 10,08Â Mld | -9,99% |
Totale passivo | 5,64Â Mld | -15,06% |
Patrimonio netto totale | 4,45 Mld | — |
Azioni in circolazione | 137,62 Mln | — |
Prezzo/valore contabile | 0,47 | — |
Redditività dell'attivo | 2,32% | — |
Rendimento sul capitale | 2,81% | — |
Flusso di cassa
Flusso di cassa netto
| (USD) | set 2025info | Variazione Y/Y |
|---|---|---|
Utile netto | 7,50Â Mln | 135,71% |
Liquidità di esercizio | 51,70 Mln | 22,51% |
Contanti da investimenti | -21,40Â Mln | -110,06% |
Contanti da finanziamenti | -50,30Â Mln | -107,70% |
Flusso di cassa netto | -22,10Â Mln | -102,40% |
Flusso di cassa libero | -173,31Â Mln | -178,91% |
Informazioni
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters in Grand Rapids, Michigan, within Michigan State University's Grand Rapids Innovation Park.
Perrigo engages in the acquisition, manufacture, and sale of consumer healthcare products, generic prescription drugs, and active pharmaceutical ingredients, primarily in the United States, from its base in Ireland. On 21 December 2018, Perrigo suffered its biggest one-day share price fall in its history after the Irish Revenue Commissioners issued a tax claim against Perrigo that equated to half of its market value. Wikipedia
Fondazione
1887
Sito web
Dipendenti
8.379